Why Blackstone and Ferring are investing $570M in a new gene therapy
November 26, 2019 at 05:30 AM EST
Ferring Pharmaceuticals and Blackstone Life Sciences said Monday that they will jointly invest $570 million in a gene therapy being developed for patients with a form of hard-to-treat bladder... To view the full story, click the title link.
